Voloridge Investment Management
RVMD icon

Voloridge Investment Management’s Revolution Medicines RVMD Stock Holding History

Voloridge Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-368,325
Closed -$35.8M – 1046
2026
Q1 		$35.8M Buy
368,325
+46,036
+14% +$4.65M 0.14% 199
2025
Q4 		$25.7M Buy
322,289
+173,144
+116% +$11.4M 0.09% 289
2025
Q3 		$6.97M Buy
149,145
+114,179
+327% +$4.47M 0.02% 644
2025
Q2 		$1.29M Buy
34,966
+2,600
+8% +$99.9K ﹤0.01% 998
2025
Q1 		$1.14M Sell
32,366
-15,485
-32% -$629K ﹤0.01% 1031
2024
Q4 		$2.09M Buy
47,851
+21,337
+80% +$1.08M 0.01% 935
2024
Q3 		$1.2M Sell
26,514
-13,771
-34% -$600K ﹤0.01% 1005
2024
Q2 		$1.56M Sell
40,285
-30,548
-43% -$1.14M 0.01% 987
2024
Q1 		$2.28M Buy
+70,833
New +$2.1M 0.01% 828
2023
Q2 		– Sell
-27,033
Closed -$586K – 1535
2023
Q1 		$586K Sell
27,033
-69,077
-72% -$1.7M ﹤0.01% 1199
2022
Q4 		$2.29M Sell
96,110
-154,461
-62% -$3.28M 0.01% 927
2022
Q3 		$4.94M Buy
250,571
+138,437
+123% +$3.04M 0.03% 656
2022
Q2 		$2.19M Buy
112,134
+19,309
+21% +$376K 0.01% 988
2022
Q1 		$2.37M Buy
+92,825
New +$2.02M 0.01% 888
2021
Q4 		– Sell
-53,384
Closed -$1.47M – 1813
2021
Q3 		$1.47M Buy
53,384
+39,683
+290% +$1.16M 0.01% 1157
2021
Q2 		$435K Sell
13,701
-36,440
-73% -$1.27M ﹤0.01% 1463
2021
Q1 		$2.3M Sell
50,141
-37,194
-43% -$1.67M 0.02% 774
2020
Q4 		$3.46M Buy
+87,335
New +$3.45M 0.03% 558

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Voloridge Investment Management's RVMD Position: Q2 2026 in Review

Voloridge Investment Management sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 368,325 shares — an estimated $35.8M sold.

Voloridge Investment Management first reported a position in RVMD in Q4 2020 and held it in 18 quarters. The position peaked at $35.8M in Q1 2026. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Voloridge Investment Management reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 368,325 Revolution Medicines shares in Q2 2026, an estimated $35.8M.
  • Voloridge Investment Management first reported a position in Revolution Medicines in Q4 2020 and held it in 18 quarters.
  • Voloridge Investment Management's Revolution Medicines position peaked at $35.8M in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.